ENASIDENIB MESYLATE
Enasidenib targets mutant IDH2, restoring normal cellular differentiation in AML. Side effects include differentiation syndrome, jaundice, and nausea.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
Enasidenib mesylate is a selective inhibitor of mutant isocitrate dehydrogenase‑2 (IDH2). Mutant IDH2 converts α‑ketoglutarate to 2‑hydroxyglutarate (2‑HG), an oncometabolite that blocks cell differentiation. Enasidenib reduces 2‑HG levels, restoring normal differentiation pathways.
Benefits and Advantages
Used in IDH‑mutation research, metabolic‑oncology modelling, differentiation‑restoration assays, and epigenetic‑reprogramming studies.
Side Effects and Risks
Risks include differentiation syndrome, hyperbilirubinemia, leukocytosis, diarrhea and fatigue. Handle with targeted‑oncology‑drug precautions.
Datasheet
| Molecular Formula | C15H14N8O·CH4O3S |
|---|---|
| Molecular Weight | 569.5 g/mol |
| CAS Number | 1650550-25-6 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| Synonym | Enasidenib mesylate; 1650550-25-6; AG-221 mesylate; Enasidenib mesilate; Enasidenib methanesulfonate |
| IUPAC/Chemical Name | methanesulfonic acid;2-methyl-1-[[4-[6-(trifluoromethyl)-2-pyridinyl]-6-[[2-(trifluoromethyl)-4-pyridinyl]amino]-1,3,5-triazin-2-yl]amino]propan-2-ol |
| InChl Key | ORZHZQZYWXEDDL-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C19H17F6N7O.CH4O3S/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25;1-5(2,3)4/h3-8,33H,9H2,1-2H3,(H2,26,27,28,30,31,32);1H3,(H,2,3,4) |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

